Citation: | WU Lian-peng, HE Gui-qing, HU Xing-zhong, PAN Yong, TANG Shao-hua. Analysis of clinical characteristics and risk factors of death in 51 AIDS patients with disseminated Talaromycosis marneffei in Wenzhou[J]. Chinese Journal of General Practice, 2021, 19(8): 1398-1402. doi: 10.16766/j.cnki.issn.1674-4152.002070 |
[1] |
SON V T, KHUE P M, STROBEL M. Penicilliosis and AIDS in Haiphong, Vietnam: evolution and predictive factors of death[J]. Med Mal Infect, 2014, 44(11-12): 495-501. doi: 10.1016/j.medmal.2014.09.008
|
[2] |
中华医学会感染病学分会艾滋病丙型肝炎学组. 中国艾滋病诊疗指南(2018版)[J]. 协和医学杂志, 2019, 10(1): 31-52. doi: 10.3969/j.issn.1674-9081.2019.01.006
|
[3] |
王星, 董明亮. 33例艾滋病伴播散性马尔尼菲青霉菌病患者的临床分析及其对抗真菌治疗的影响[J]. 抗感染药学, 2019, 16(1): 72-75. https://www.cnki.com.cn/Article/CJFDTOTAL-KGYY201901030.htm
|
[4] |
秦英梅, 董文逸, 吴念宁, 等. 艾滋病合并马尔尼菲篮状菌病的研究现状[J]. 中国热带医学, 2020, 20(6): 572-577. https://www.cnki.com.cn/Article/CJFDTOTAL-RDYX202006021.htm
|
[5] |
"十三五"国家科技重大专项艾滋病机会性感染课题组. 艾滋病合并马尔尼菲篮状菌病临床诊疗的专家共识[J]. 西南大学学报(自然科学版), 2020, 42(7): 61-75. https://www.cnki.com.cn/Article/CJFDTOTAL-XNND202007005.htm
|
[6] |
CHEN J, ZHANG R, SHEN Y, et al. Clinical characteristics and prognosis of penicilliosis among human immunodeficiency virus-infected patients in eastern china[J]. Am J Trop Med Hyg, 2017, 9(6): 1380-1354. doi: 10.4269/ajtmh.16-0521?crawler=true&mimetype=application/pdf
|
[7] |
陈兴. 艾滋病合并马尔尼菲青霉病187例的流行病学、临床特点、治疗及转归分析[J]. 中国医药科学, 2018, 8(11): 17-21. https://www.cnki.com.cn/Article/CJFDTOTAL-GYKX201811006.htm
|
[8] |
施伎蝉, 蒋贤高, 刘赛朵, 等. 艾滋病合并播散性马尔尼菲蓝状菌病25例临床特征分析[J]. 中华医院感染学杂志, 2019, 29(24): 3706-3709, 3714. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201924008.htm
|
[9] |
张米, 雷素云, 高丽, 等. 艾滋病合并马尔尼菲青霉菌感染的流行病学特点及实验室特征[J]. 临床医药文献电子杂志, 2015, 2(21): 4291-4292. https://www.cnki.com.cn/Article/CJFDTOTAL-LCWX201521001.htm
|
[10] |
陈媛媛, 刘旭辉, 侯明杰, 等. 58例艾滋病合并马尔尼菲青霉菌病病人临床特征分析[J]. 中国艾滋病性病, 2018, 24(1): 30-32, 52. https://www.cnki.com.cn/Article/CJFDTOTAL-XBYA201801009.htm
|
[11] |
LI X L, ZHENG Y Q, WU F Y, et al. Evaluation of quantitative real-time PCR and palatedlia galactomannan assays for the diagnosis of diverseminated talaromyces marneffei infection[J]. Med Mycol, 2020, 58(2): 181-186. http://www.researchgate.net/publication/333445552_Evaluation_of_quantitative_real-time_PCR_and_Platelia_galactomannan_assays_for_the_diagnosis_of_disseminated_Talaromyces_marneffei_infection
|
[12] |
黄维, 李勇, 覃善芳, 等. 25例艾滋病合并马尔尼菲篮状菌肺炎的床分析[J]. 新发传染病电子杂. 2019, 4(4): 223-226. doi: 10.3877/j.issn.2096-2738.2019.04.009
|
[13] |
LIU D H, WEI L L, GUO T, et al. Detection of DOPA-melanin in the dimorphic fungal pathogen Penicillium marneffei and its effect on macrophage phagocytosis in vitro[J]. PLoS One, 2014, 9(3): 0092610-1-0092610-7. http://pdfs.semanticscholar.org/791b/be70a9ea0640124aab0316502006e6a54ed2.pdf
|
[14] |
何小庆, 鲁雁秋, 周怡宏, 等. 重庆地区56例AIDS合并播散性马尔尼菲篮状菌病患者临床特征及死亡危险因素分析[J]. 传染病信息, 2018, 31(6): 521-524. doi: 10.3969/j.issn.1007-8134.2018.06.006
|
[15] |
张培燕, 李建明, 何云, 等. 53例艾滋病合并马尔尼菲蓝状菌感染者的临床特点[J]. 中国热带医学, 2019, 19(9): 893-895. https://www.cnki.com.cn/Article/CJFDTOTAL-RDYX201909021.htm
|
[16] |
LE T, KINH N V, CUC N T K, et al. A trial of itraconazole or amphotericin B for HIV-associated talaromycosis[J]. N Eng J Med, 2017, 376(24): 2329-2340. doi: 10.1056/NEJMoa1613306
|
[17] |
OUYANG Y Y, CAI S Q, LIANG H, et al. Aministration of voriconazol in disseminated talaromyces(penicillium) marneffei infection: a retrospective study[J]. Mycopathologia, 2017, 182(5-6): 569-575. doi: 10.1007/s11046-016-0107-3
|
[18] |
ARIAS A A, PEREZVELEZ C M, ORREGO J C, et al. Severe enter opathy and hypogammaglobulinemia complicating refractory mycobacterium tuberculosis complex disseminated disease in a child with IL-12Rβ1 deficiency[J]. J Clinical Immunol, 2017, 37(7): 732-738. doi: 10.1007/s10875-017-0435-1
|
[19] |
张云桂, 杨欣平, 李玉叶, 等. 艾滋病合并马尔尼菲篮状菌病82例临床和预后分析[J]. 中国艾滋病性病, 2019, 25(7): 687-690, 727. https://www.cnki.com.cn/Article/CJFDTOTAL-XBYA201907010.htm
|